Home  >  Health Check  >  Milestone in HIV prevention for women
Health Check
Milestone in HIV prevention for women
Health Check
Dec 2, 2020

In the week of World AIDS Day, Health Check looks at what's being described as a milestone in the prevention of HIV infection in women. It is a form of pre-exposure prophylaxis (PrEP) - an injection every 8 weeks of a drug called cabotegravir. A clinical trial has been comparing it to a daily PrEP pill which is already known to be effective at preventing HIV infection. The injection regimen was about 90% more effective at shielding women from the virus than the daily tablet. The trial involves more than 3,000 women in seven Southern and East African countries. Claudia talks to study co-leader Sinead Delany-Moretlwe of the University of Witwatersrand about why this form of PrEP seems to be so effective and whether it will be affordable for low and middle income countries. Chhavi Sachdev reports on informal health workers known as ‘chhota doctors’ who are the backbone of primary health care for the hundreds of millions of rural people in India. They are not formally recognised as health care providers by the authorities and lack medical degrees, but they are the first port of call for many when people feel ill, particularly during India’s coronavirus lockdown. At a time when so many people are stuck indoors working at home, World Health Organisation has published new recommendations on how much physical activity we should be doing for the sake of our health. We talk to Fiona Bull, head of the WHO’s physical activity unit. James Gallagher is the Health Check guest this week talking about Covid-19 vaccines, vitamin D and a step towards a blood test to predict Alzheimer’s disease.

Presenter: Claudia Hammond Producer: Andrew Luck-Baker

(Picture: Female doctor giving a young female patient an injection in her consultation room. Photo credit: Henk Badenhorst/Getty Images.)

More Episodes

Jun 24, 2026
Lack of evidence most IVF ‘add-ons’ improve fertility

Many people with infertility use in vitro fertilisation (IVF), however the probability of having a baby following IVF is only approximately 30-40% per cycle and decreases significantly with age. It can be a lengthy and expensive process. Providers sometimes offer ‘add-ons’, additional treatments that they claim could help patients conceive, which are themselves also usually expensive. In Australia, New Zealand and the United Kingdom more than 70% of patients pay for at least one of these add-ons. A new review published in The Lancet Obstetrics, Gynaecology, & Women’s Health journal has found that evidence on the benefits of these add-on treatments is unclear. Claudia Hammond speaks to Dr Sarah Lensen, Senior Research Fellow in the Department of Obstetrics, Gynaecology and Newborn Health at the University of Melbourne.

Joining Claudia from Ghana is genito-urinary consultant and HIV expert, Vanessa Apea. Claudia and Vanessa discuss a draft African Charter on Family, Sovereignty and Values, which claims that comprehensive sex education, as well as a range of sexual and reproductive health rights, are a threat to African families from foreign ideologies.

They also discuss a report from the Office of Inspector General of US Agency for International Development (USAID) which reveals that President Donald Trump’s administration has spent hundreds of thousands of dollars in storage and transportation costs for $9.7 million worth of contraceptives that are being stored in Belgium rather than distributed to the various low-income countries they were intended for. Many of the withheld contraceptives are now expired or unusable due to their removal from temperature-controlled storage.

We also hear from Health Check reporter Jane Chambers in the Chilean city of Valdivia, where wetlands are part of everyday life—and increasingly, part of people’s health. And we hear how faecal-microbiome transplants could improve the efficacy of some antidepressants in patients with major depressive disorder.

Presenter: Claudia Hammond Producers: Jonathan Blackwell & Georgia Christie


26min 29sec



Milestone in HIV prevention for women

--:--
--:--